Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 823 results for "Novartis Company"

Novartis SEG101 (crizanlizumab, formerly SelG1) significantly reduces frequency of sickle cell pain crises in ...

Novartis SEG101 (crizanlizumab, formerly SelG1) significantly ...

SEG101 reduced annual rate of sickle cell-related pain crises (SCPC) by 45.3% compared to placebo in patients with or without hydroxyurea therapy SEG101 is a potential new disease-modifying, preventive treatment option for patients with SCPC; ..., 1 day ago

148 images for Novartis Company

Reuters India, 1 day ago
Yahoo! India, 1 day ago
Channel NewsAsia, 1 day ago
International Business Times India, 1 day ago
SleekMoney, 18 hours ago
Business Insider, 1 week ago
Yahoo! News, 2 weeks ago, 2 weeks ago
Business Insider, 3 weeks ago
Yahoo! News, 3 weeks ago

Sun Pharma, Wockhardt in news on re-inspections, lawsuits

Wockhardt, Sun Pharma, Tara, Novartis and other pharma company Perrigo are also in focus on account of reports from the US that there are lawsuits filed by Unions representing the New York Police Department on price collusion of two dermatology products.
 Money Control2 weeks ago Remedy Pharmaceuticals appoints special advisor to board of directors  PredictWallStreet3 days ago David Epstein Joins as Special Advisor to Remedy Pharmaceuticals  Financial Buzz4 days ago Ex-Novartis chief Epstein joins Remedy Pharmaceuticals  pharmaphorum5 days ago
Channel NewsAsia

Novartis CEO plays down prospects for Actelion bid: Blick

CEO Joe Jimenez of Swiss pharmaceutical company Novartis addresses the company's annual news conference in Basel, Switzerland January 27, 2016. REUTERS/Arnd WiegmannMore VIENNA (Reuters) - Novartis Chief Executive Joe Jimenez has played down ...
 Yahoo! Finance1 day ago Novartis hosts breakthrough partner summit  Cover Publications1 week ago Novartis just picked up a blood disease company for $665 million (NVS)  Business Insider2 weeks ago

Novartis Q2 net profit at Rs 22.21 cr

Pharma company Novartis India today reported a standalone net profit of Rs 22.21 crore for the quarter ended September 30, 2016. The company had posted a net profit of Rs 103.69 crore a year ago. Total income from operations during the quarter ...
 Business Standard3 weeks ago

Novartis India's board meeting on November 11, 2016

Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on November 11, 2016, inter alia, to consider unaudited financial results of the Company for the second quarter and half year ended September 30, 2016.
 Money Control1 month ago

Concerns over ‘non-availability’ of Novartis’ thalassemia drug

But pharma company maintains there is no shortage Mumbai, Sept 9: Earlier this week, a petition addressed to Health Minister JP Nadda raised concerns over the non-availability of Desferal, an injectable drug used to reduce excess iron in the blood for people ...
 Business Line2 months ago
Zolmax News

Novartis AG (NVS) Shares Sold by Penobscot Investment Management Company Inc.

Penobscot Investment Management Company Inc. decreased its stake in Novartis AG (NYSE:NVS) by 13.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,976 ...
 Mideast Time1 week ago Neuberger Berman Group LLC Has $33,157,000 Position in Novartis AG (NVS)  Zolmax News57 minutes ago Charter Trust Co. Cuts Stake in Novartis AG (NVS)  Ticker Report2 days ago Oppenheimer & Co. Inc. Sells 1,006 Shares of Novartis AG (NVS)  Zolmax News2 days ago

Novartis bolts on hematology/inflammation company Selexys

BASEL, Switzerland—Consistent both with Novartis CEO Joe Jiminez's stated interest in bolt-on acquisitions and the company's interest in expanding its hematology presence and portfolio, Novartis announced Nov. 21 that it had acquired Selexys ...
 Drug Discovery News1 week ago NOVARTIS : Payments to Healthcare Professionals  4 Traders6 days ago Novartis acquires US company  Switzerland Global Enterprise1 week ago

Novartis Testing Strategies To Improve Pricing, Access To Certain Medicines In Developing Countries

Humanosphere : Drug companies test out new strategies for improving access in poor countries David J. Olson, a global development communications and social marketing consultant, highlights how pharmaceutical company Novartis is trying to improve ...
 Kaiser Network.org6 days ago Drug companies test out new strategies for improving access in poor countries  Humanosphere1 week ago

Chiesi buys asthma company, pitting it against Novartis

Brief Author By @suzannewriter • Published Nov. 22, 2016 Dive Brief: Privately-owned Italian pharma Chiesi Farmaceutici has snapped up the asthma-focused biotech Atopix Therapeutics, buying all outstanding shares and assets in ...
 BioPharma Dive1 week ago Novartis donates $10M in generics to global relief  BioPharma Dive6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less